Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series.
- 1Department of Vascular Surgery, LongHua Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Abstract
Objective
To analyze the possible etiology and evaluate the technical and clinical outcomes of using bare metal stents for the treatment of central venous stenosis (CVS) in the lower extremity with ipsilateral hemodialysis access.Methods
A single-center retrospective analysis of a small case series was conducted in hemodialysis patients with lower extremity arteriovenous grafts (AVG) who were treated with bare metal stents (BMS) for symptomatic iliac vein stenosis between April 2016 and June 2021. Patients' demographic data, technical details, adverse events, clinical outcomes, and imaging data were recorded.Results
The study cohort comprised seven females and four males, with a mean age of 58.8 ± 13.4 years. Preoperative lower limb venography was performed in nine patients scheduled for AVG creation. With the exception of one case demonstrating left iliac vein compression, the iliac veins were patent in all other patients. Symptoms of lower limb swelling developed at a mean interval of 9.40 ± 5.83 months (range: 3-20 months) following AVG placement. Eight cases had a concomitant history of temporary ipsilateral femoral vein catheterization. Lesion characteristics included nine stenotic lesions and two occlusive lesions. All patients were treated with SMART Control stents (Cordis Corp, USA). The technical success rate was 100%, and symptomatic relief was achieved in all cases. Over a mean follow-up period of 47.8 ± 31.7 months (range: 10-123 months), the target lesion primary patency was 100% (one-side confidence interval [CI] = 0.74,1).Conclusions
Using BMS is a safe and effective method to treat iliac vein stenosis with ipsilateral AVG.
Related
- Commentary to: Carotid Stenting for Asymptomatic Carotid Stenosis: Call for Judicious Approach
- Innovative application of pressure gradient measurement in internal carotid stenosis in patients undergoing carotid artery stenting (NOTICE-CAS): study protocol for a randomized, assessor-blinded, parallel-group clinical trial
- Recurrent Ischemic Stroke after Carotid Artery Stenting for Thyroid Cartilage Induced CCA Stenosis: Was Stenting an Appropriate Treatment?
- Intravascular Ultrasound-Guided Iliofemoral Venous Stenting: In-Stent Mural Thrombus as a Possible Early Sign of Occult Malignancy
- Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study
BibTeX
@article{shi2026longterm,
title = {{Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series.}},
author = {Yaxue Shi and Xuedong Bao and Xinyi Fu and Lanhua Mi and Sijie Liu and Chang Wu},
journal = {Renal failure},
year = {2026},
month = oct,
doi = {10.1080/0886022x.2026.2742581},
url = {https://europepmc.org/article/MED/42902602},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series.
AU - Yaxue Shi
AU - Xuedong Bao
AU - Xinyi Fu
AU - Lanhua Mi
AU - Sijie Liu
AU - Chang Wu
PY - 2026
DA - 2026/10/20
JO - Renal failure
DO - 10.1080/0886022x.2026.2742581
UR - https://europepmc.org/article/MED/42902602
AB - Objective To analyze the possible etiology and evaluate the technical and clinical outcomes of using bare metal stents for the treatment of central venous stenosis (CVS) in the lower extremity with ipsilateral hemodialysis access.Methods A single-center retrospective analysis of a small case series was conducted in hemodialysis patients with lower extremity arteriovenous grafts (AVG) who were treated with bare metal stents (BMS) for symptomatic iliac vein stenosis between April 2016 and June 2021. Patients' demographic data, technical details, adverse events, clinical outcomes, and imaging data were recorded.Results The study cohort comprised seven females and four males, with a mean age of 58.8 ± 13.4 years. Preoperative lower limb venography was performed in nine patients scheduled for AVG creation. With the exception of one case demonstrating left iliac vein compression, the iliac veins were patent in all other patients. Symptoms of lower limb swelling developed at a mean interval of 9.40 ± 5.83 months (range: 3-20 months) following AVG placement. Eight cases had a concomitant history of temporary ipsilateral femoral vein catheterization. Lesion characteristics included nine stenotic lesions and two occlusive lesions. All patients were treated with SMART Control stents (Cordis Corp, USA). The technical success rate was 100%, and symptomatic relief was achieved in all cases. Over a mean follow-up period of 47.8 ± 31.7 months (range: 10-123 months), the target lesion primary patency was 100% (one-side confidence interval [CI] = 0.74,1).Conclusions Using BMS is a safe and effective method to treat iliac vein stenosis with ipsilateral AVG.
SN - 0886-022X
SN - 1525-6049
ER -